1 of 1
Story summary
- Cathy Tie, founder of Origin Genomics, is urging public funding for gene-edited embryos in IVF clinics.
- Origin Genomics launched in March to develop clinical germ-line editing.
- Tie called gene-editing a “moral imperative” in a Trends in Genetics commentary.
- She urged new regulatory pathways for germ-line editing.
- Law professor Hank Greely warned that early human trials caused deaths without “flashing red lights.”
